SNX Insider: 861 Options Exercised at $57.34; 861 Shares Sold at $147.50

Rhea-AI Filing Summary

Witt Marshall, Chief Financial Officer of TD SYNNEX Corporation (SNX), reported transactions on 08/18/2025. The filing shows an exercise of 861 employee stock options at an exercise price of $57.34 per share and a contemporaneous sale of 861 common shares at $147.50 per share. After these transactions the reporting person’s direct beneficial ownership is reported as 49,777 shares for common stock and 8,610 shares held from vested options/derivatives. The reporting person adopted a Rule 10b5-1 trading plan on May 12, 2025, and the filing is signed by an attorney-in-fact on 08/19/2025. The option vests 20% after one year and then 1/60th monthly thereafter.

Positive

• Transactions executed under a Rule 10b5-1 plan adopted May 12, 2025, which supports transparency and compliance with insider trading rules
• Option exercise disclosed with vesting schedule (20% after one year, then 1/60th monthly), providing clarity on compensation timing and future potential dilution

Negative

• Insider sale of 861 shares reduced direct beneficial ownership from 50,638 to 49,777 shares

Insights

Corporate Governance Expert

TL;DR: Routine, pre-planned option exercise and sale under a 10b5-1 plan increases transparency and reduces appearance of opportunistic trading.

The Form 4 discloses an exercise of 861 employee stock options at $57.34 and a simultaneous sale of 861 shares at $147.50 executed pursuant to a Rule 10b5-1 trading plan adopted May 12, 2025. Filing by an attorney-in-fact is properly executed. The filing also documents the option vesting schedule, which helps auditors and governance professionals confirm compliance with insider-trading policies. This is a standard insider liquidity event rather than a material corporate governance change.

Securities Analyst

TL;DR: Small-scale insider exercise and sale under plan; limited direct impact on company capitalization or control.

The transactions involve 861 shares and do not materially move outstanding share counts for a company of TD SYNNEX’s size. The exercise price of $57.34 and sale price of $147.50 are clearly reported, and post-transaction direct holdings are stated. Because the sale was executed under a pre-existing Rule 10b5-1 plan, this represents routine insider monetization rather than an ad-hoc decision based on nonpublic information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Witt Marshall

(Last) (First) (Middle)

44201 NOBEL DRIVE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		M		861	A	$57.34	50,638	D
Common Stock	08/18/2025		S(1)		861	D	$147.5	49,777	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$57.34	08/18/2025		M			861	(2)	10/04/2026	Common Stock	861	$0	8,610	D

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

	/s/ Cheryl Grant, attorney-in-fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did the SNX reporting person make on 08/18/2025?

They exercised 861 employee stock options at an exercise price of $57.34 and sold 861 common shares at $147.50 on 08/18/2025.

Was the sale for SNX executed under a trading plan?

Yes. The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

How many SNX shares does the reporting person beneficially own after the transactions?

Following the reported transactions the reporting person directly beneficially owns 49,777 common shares and holds 8,610 shares from derivative securities.

What is the vesting schedule for the exercised options?

The option vests 20% on the first anniversary of grant and then vests at 1/60th of the shares monthly thereafter.

Who signed the Form 4 filing?

The Form 4 was signed by Cheryl Grant, attorney-in-fact, on 08/19/2025.